Europe Cardiac Biomarkers Testing Market By Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others), By Location of Testing (Point of Care Testing and Laboratory Testing)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Cardiac Biomarkers Testing Market
Market Report Description
The Europe Cardiac Biomarkers Testing Market would witness market growth of 11.1% CAGR during the forecast period (2019-2025). The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added a boost to market growth. Additionally, promising features like high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing is further driving the growth of the market across the globe. To keep the momentum of cardiac marker tests, the key manufacturers offer customized solutions. The commercial application of multi-menu options, which are meant for cardiac testing done through different combinations of cardiac biomarkers and target-oriented solutions, are the major opportunities of the market. However, limited specificity in some cases and side effects such as skeletal muscle injury is restraining the growth cardiac biomarkers markets.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Cardiac Biomarkers Testing Market Analysis
Market Segmentation:
By Type
- Creatine Kinase (CK-MB)
- Troponins
- Myoglobin
- Natriuretic Peptides (BNP and NT-proBNP)
- Ischemia Modified Albumin
- Others
By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
By Location of Testing
- Point of Care Testing
- Laboratory Testing
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Trivitron Healthcare Pvt. Ltd.
- Abbott Laboratories
- Siemens AG
- Becton, Dickinson AND Company
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Limited
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson and Johnson
- Quidel Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free